UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Point-Counterpoint: Gleason Score 6/Grade Group 1 Prostate Cancer Should Be Renamed as "Non-cancer" to Improve Public Health: A Wrong Idea From a Pathologist's Perspective

The Journal of urology, 2023-07, Vol.210 (1), p.21-22

Shah, Rajal B

2023

Volltextzugriff (PDF)

Renal Cell Carcinoma With Fibromyomatous Stroma-The Whole Story

Advances in anatomic pathology, 2022-05, Vol.29 (3), p.168-177

Shah, Rajal B

2022

Volltextzugriff (PDF)

Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up

Advances in anatomic pathology, 2024-03, Vol.31 (2), p.105-117

2024

Volltextzugriff (PDF)

Hot Topics in Urologic Pathology

Advances in anatomic pathology, 2024-03, Vol.31 (2), p.59-60

2024

Volltextzugriff (PDF)

Prostate Biopsy Interpretation: An Illustrated Guide

Second edition., 2019

Volltextzugriff (PDF)

Recent advances in prostate cancer pathology: Gleason grading and beyond

Pathology international, 2016-05, Vol.66 (5), p.260-272

2016

Volltextzugriff (PDF)

HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone

Cancer research (Chicago, Ill.), 2017-01, Vol.77 (1), p.74-85

2017

Volltextzugriff (PDF)

Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital

Urologic oncology, 2013-11, Vol.31 (8), p.1650-1655

2013

Volltextzugriff (PDF)

Reply to ‘Low‐grade intraductal carcinoma of the prostate: an idea whose time has not yet come’: evidence‐based medicine suggests that the time is now

Histopathology, 2017-11, Vol.71 (5), p.839-840

Shah, Rajal B

2017

Volltextzugriff (PDF)

Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma

Histopathology, 2017-11, Vol.71 (5), p.693-702

2017

Volltextzugriff (PDF)

"Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity

The American journal of surgical pathology, 2020-05, Vol.44 (5), p.571-581

2020

Volltextzugriff (PDF)

PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma)

The Prostate, 2019-08, Vol.79 (11), p.1267-1273

2019

Volltextzugriff (PDF)

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (10), p.3933-3938

2008

Volltextzugriff (PDF)

Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer

Neoplasia (New York, N.Y.), 2008-02, Vol.10 (2), p.177,IN1-188,IN9

2008

Volltextzugriff (PDF)

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

Nature, 2007-08, Vol.448 (7153), p.595-599

2007

Volltextzugriff (PDF)

Enrichment of “Cribriform” morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer

Modern pathology, 2022-10, Vol.35 (10), p.1468-1474

2022

Volltextzugriff (PDF)

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

Cancer research (Chicago, Ill.), 2008-05, Vol.68 (10), p.3584-3590

2008

Volltextzugriff (PDF)

A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (22), p.10657-10663

2007

Volltextzugriff (PDF)

Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy

The American journal of surgical pathology, 2015-02, Vol.39 (2), p.169-178

2015

Volltextzugriff (PDF)

SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial

International journal of radiation oncology, biology, physics, 2022-06, Vol.113 (2), p.290-301

2022

Volltextzugriff (PDF)

Should grade group 1 prostate cancer be reclassified as “non-cancer”? A pathology community perspective

Urologic oncology, 2023-02, Vol.41 (2), p.62-64

2023

Volltextzugriff (PDF)

Cribriform Lesions of the Prostate Gland

Surgical pathology clinics, 2022-12, Vol.15 (4), p.591-608

2022

Volltextzugriff (PDF)

Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling

Human pathology, 2015-05, Vol.46 (5), p.698-706

2015

Volltextzugriff (PDF)

Preoperative Multiparametric Prostate Magnetic Resonance Imaging Structured Report Informs Risk for Positive Apical Surgical Margins During Radical Prostatectomy

Journal of computer assisted tomography, 2023-01, Vol.47 (1), p.38-44

2023

Volltextzugriff (PDF)

The role of the radiologist in the prostate cancer multidisciplinary conference

Abdominal radiology (New York), 2024-07

2024

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(164)

Publikationsform

Artikel
(229)
Buchkapitel
(20)
Bücher
(1)

Sprache

Englisch
(250)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Point-Counterpoint: Gleason Score 6/Grade Group 1 Prostate Cancer Should Be Renamed as "Non-cancer" to Improve Public Health: A Wrong Idea From a Pathologist's Perspective

Renal Cell Carcinoma With Fibromyomatous Stroma-The Whole Story

Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up

Hot Topics in Urologic Pathology

Prostate Biopsy Interpretation: An Illustrated Guide

Recent advances in prostate cancer pathology: Gleason grading and beyond

HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone

Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital

Reply to ‘Low‐grade intraductal carcinoma of the prostate: an idea whose time has not yet come’: evidence‐based medicine suggests that the time is now

Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma

"Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity

PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma)

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

Enrichment of “Cribriform” morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome

Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy

SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial

Should grade group 1 prostate cancer be reclassified as “non-cancer”? A pathology community perspective

Cribriform Lesions of the Prostate Gland

Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling

Preoperative Multiparametric Prostate Magnetic Resonance Imaging Structured Report Informs Risk for Positive Apical Surgical Margins During Radical Prostatectomy

The role of the radiologist in the prostate cancer multidisciplinary conference

Suchergebnisse filtern